Ligand profile
1AV
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_4030 — DNA topoisomerase IV, B subunit
Identifiers
Database identifiers and provenance.
- Ligand ID
1AV- PDB
4hz0- UniProt (similar protein)
P20083- Target protein
- VK055_4030
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 95.4
- −1 ≤ LogP ≤ 5 1.92
- MW ≤ 500 Da 295.3
- LogP ≤ 5 1.92
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 8
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 95.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1cc(cnc1)c2nc3c(nc(nc3s2)N)n4ccnc4c1cc(cnc1)c2nc3c(nc(nc3s2)N)n4ccnc4
InChI=1S/C13H9N7S/c14-13-18-10(20-5-4-16-7-20)9-12(19-13)21-11(17-9)8-2-1-3-15-6-8/h1-7H,(H2,14,18,19)InChI=1S/C13H9N7S/c14-13-18-10(20-5-4-16-7-20)9-12(19-13)21-11(17-9)8-2-1-3-15-6-8/h1-7H,(H2,14,18,19)
FTDVRDNCBWDKFI-UHFFFAOYSA-NFTDVRDNCBWDKFI-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF02518
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 1AV →
- PDB RCSB structure 4hz0 →
- UniProt UniProt P20083 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “1AV”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4030.
PDB 19
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 18
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).